PulseAugur
EN
LIVE 22:15:01

White House funds ibogaine research for veteran PTSD

The White House is funding studies into the use of ibogaine to treat Post-Traumatic Stress Disorder (PTSD) in veterans. This initiative reflects a more permissive regulatory environment and administrative enthusiasm for psychedelic research, potentially signaling a new phase for such investigations. AI

RANK_REASON Significant funding from a government entity for a novel research area. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

White House funds ibogaine research for veteran PTSD

How we ranked this

Signal score
4 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Significant funding from a government entity for a novel research area. [lever_c_demoted from significant: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
policy, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Joshua P. Cohen, Senior Contributor ·

    Balancing Promise And Risk: White House Funds Ibogaine Studies For Veteran PTSD

    With more flexible regulatory guidance and an administration that appears enthused about prospects for psychedelics, it’s possible we’ve entered a new era for research.